140 related articles for article (PubMed ID: 17325128)
1. Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells.
Soller M; Dröse S; Brandt U; Brüne B; von Knethen A
Mol Pharmacol; 2007 Jun; 71(6):1535-44. PubMed ID: 17325128
[TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.
Kim SH; Yoo CI; Kim HT; Park JY; Kwon CH; Kim YK
Toxicol Appl Pharmacol; 2006 Sep; 215(2):198-207. PubMed ID: 16616945
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of oxidant production by peroxisome proliferator-activated receptor ligands from cell death in human cell lines.
Atarod EB; Kehrer JP
Free Radic Biol Med; 2004 Jul; 37(1):36-47. PubMed ID: 15183193
[TBL] [Abstract][Full Text] [Related]
4. Ciglitazone induces apoptosis via activation of p38 MAPK and AIF nuclear translocation mediated by reactive oxygen species and Ca(2+) in opossum kidney cells.
Kwon CH; Park JY; Kim TH; Woo JS; Kim YK
Toxicology; 2009 Mar; 257(1-2):1-9. PubMed ID: 19110029
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells.
Huang JW; Shiau CW; Yang YT; Kulp SK; Chen KF; Brueggemeier RW; Shapiro CL; Chen CS
Mol Pharmacol; 2005 Apr; 67(4):1342-8. PubMed ID: 15653552
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells.
Chang HK; Kim DS; Chae JJ; Kim M; Myong JP; Lee KH; Lee MW; Park TC
Biochem Biophys Res Commun; 2017 Jan; 482(4):843-848. PubMed ID: 27888104
[TBL] [Abstract][Full Text] [Related]
7. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
Pandhare J; Cooper SK; Phang JM
J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
[TBL] [Abstract][Full Text] [Related]
8. Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.
Kang DW; Choi CH; Park JY; Kang SK; Kim YK
Neurochem Res; 2008 Mar; 33(3):551-61. PubMed ID: 17940898
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS
Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance.
Skildum A; Dornfeld K; Wallace K
Breast Cancer Res Treat; 2011 Oct; 129(3):785-97. PubMed ID: 21128112
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone induced apoptosis via PPARγ activated POX-induced ROS formation in HT29 cells.
Wang J; Lv X; Shi J; Hu X; DU Y
Biomed Environ Sci; 2011 Aug; 24(4):391-9. PubMed ID: 22108328
[TBL] [Abstract][Full Text] [Related]
12. Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.
Kwon CH; Yoon CS; Kim YK
Toxicology; 2008 Feb; 244(1):13-24. PubMed ID: 18082925
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes.
Rachek LI; Yuzefovych LV; Ledoux SP; Julie NL; Wilson GL
Toxicol Appl Pharmacol; 2009 Nov; 240(3):348-54. PubMed ID: 19632256
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of PPARgamma ligands on oxidative stress-induced death of retinal pigmented epithelial cells.
Rodrigues GA; Maurier-Mahé F; Shurland DL; McLaughlin A; Luhrs K; Throo E; Delalonde-Delaunay L; Pallares D; Schweighoffer F; Donello J
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):890-903. PubMed ID: 20847119
[TBL] [Abstract][Full Text] [Related]
16. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
[TBL] [Abstract][Full Text] [Related]
17. Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
Chopra B; Georgopoulos NT; Nicholl A; Hinley J; Oleksiewicz MB; Southgate J
Cell Prolif; 2009 Oct; 42(5):688-700. PubMed ID: 19614673
[TBL] [Abstract][Full Text] [Related]
18. Pro-MMP-2 activation by the PPARgamma agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK.
Kim KH; Cho YS; Park JM; Yoon SO; Kim KW; Chung AS
FEBS Lett; 2007 Jul; 581(17):3303-10. PubMed ID: 17597617
[TBL] [Abstract][Full Text] [Related]
19. Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.
Cheon CW; Kim DH; Kim DH; Cho YH; Kim JH
World J Gastroenterol; 2009 Jan; 15(3):310-20. PubMed ID: 19140230
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Kim KY; Ahn JH; Cheon HG
Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
